Back to Results
First PageMeta Content
University of Lugano / Antonio Lanzavecchia


BioBusiness BioEntrepreneurship Life Sciences Entrepreneurship BioClub BioBusiness
Add to Reading List

Document Date: 2014-10-20 09:04:57


Open Document

File Size: 1,19 MB

Share Result on Facebook

City

Munich / Basel / Dublin / Rockville / New York / London / /

Company

Novartis / Amgen / Granzer Regulatory Consulting / Helsinn Birex Therapeutics Ltd. / Helsinn Birex Pharmaceuticals Ltd / Helsinn Advanced Synthesis SA / FIT Executive Center USI / Zuercher / Ernst & Young SA / Granzer Regulatory Consulting & Services / Aravis SA / Micromet Inc. / Helsinn Therapeutics / Oncalis AG / Unifida Finance SA / Telormedix / Neurotune SA / ONELIFE ADVISORS SA / Helsinn Healthcare SA / Cooley LLP / Helsinn Group / Cytos Biotechnology AG / Money Bonds Investments SA / ESBATech AG / Felder / Schmauder & Partner AG / Humabs Biomed / Programme / /

Country

Switzerland / Germany / Italy / United States / Ireland / /

Currency

USD / /

Event

Business Partnership / M&A / Second Stock Issuance / /

Facility

Institute of Finance / San Raffaele Research Institute / Harvard University / University of Basel / Rensselaer Polytechnic Institute / University of Miami / Bocconi University / University of Lugano / Institute of Research / University of Zürich / /

IndustryTerm

pharmaceutical industry / biotechnology industries / law degree / start-up / pharmaceutical / biopharmaceutical / biotechnology industry / company spin-off / public relations / law / /

Organization

University of Basel / Institute of Research / Bocconi University in Milan / Rensselaer Polytechnic Institute / Institute of Finance / Senior Vice President Administration / OAD-FCT / Board of Directors of the HELSINN HOLDING SA / San Raffaele Research Institute / Harvard University / Board of Directors of Helsinn Holding SA / Executive Committee / University of Zürich / University of Miami / Mauro Martinoni Scientific committee / University of Lugano / /

Person

Università della Svizzera / Albino Zgraggen / Massimo Colnago / Riccardo Braglia / Ruggero Fariello / Matthias Alder / Lorenzo Leoni Visiting / Shreefal Mehta / Mauro Martinoni / Heidrun Flaadt Cervini / Antonio Lanzavecchia Steering / Biasca / Amal Therapeutics / Lugano / Giovanni Barone-Adesi / Enrico Braglia / Piero Martinoli Lic / /

Position

director for two hedge funds / Molecular Partners Executive Center / member of the Board / Vice President / Corporate Development and Legal Affairs / General Counsel and Secretary / Executive Center / author / executive manager / CEO / Wealth Manager and Equity Trader / Equity Trader / President and CEO / Managing Director / lecturer and group leader / Executive Vice President / Corporate Development / counsel for the pharmaceutical business / Venture Valuation Executive Center / Director the Managing / manager / Scientist / Head of Research and Collaborations / Index Ventures Executive Center / Chairman / Director / IFIN Executive Center / Martinoli President / Private / Executive / /

Product

Clinical Drug / /

ProvinceOrState

Maryland / /

PublishedMedium

Molecular Biology / /

Technology

30 Assessing Technology / biotechnology / Drug Development / /

SocialTag